ArticleInvestigational new drugs2018
Unique characteristics of regulatory approval and pivotal studies of orphan anticancer drugs in Japan.
Hiroki Nakayama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it